About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | ToRsemide for pOstpartum HYpertension

ToRsemide for pOstpartum HYpertension

NCT02813551·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

The University of Texas Health Science Center, Houston

Age

18–any

Sex

FEMALE

Healthy volunteers

Accepted

You may be eligible if

Postpartum women at ≥ 18 years of age
Antepartum/intrapartum or within 24 hours postpartum diagnosis of either:
Preeclampsia
Preeclampsia with severe features
Preeclampsia superimposed to chronic hypertension

You may not be if

Chronic hypertension without superimposed preeclampsia
Gestational hypertension
Urine output \< 30 cc/h at time of randomization
Heart failure or pulmonary edema
Hypersensitivity to Torsemide or sulfonylureas
Hypokalemia (serum potassium \< 3 mEq/L)
Preexisting diuretic use within 24 hours prior to randomization

The record

StatusCompleted

PhasePhase 2

Taking part118

StartedAug 2016

UpdatedApr 10, 2019

Conditions

Where1

The University of Texas Health Science Center
Houston, Texas, United States